The chemical class of AHI1 Activators represents a group of compounds specifically targeting the upregulation and activation of the AHI1 protein, a key player in certain cellular mechanisms, especially within the brain. AHI1, an acronym for Abelson Helper Integration Site 1, is integral to various cellular processes, including those related to the development and functioning of neuronal structures. Activators in this class achieve their effects through multiple molecular pathways, each uniquely influencing either the AHI1 gene or its protein product. Some activators enhance the transcription of the AHI1 gene, leading to increased mRNA production and, consequently, higher protein synthesis. This transcriptional upregulation is often mediated through epigenetic modifications like altered DNA methylation or changes in histone acetylation, making the AHI1 gene more amenable to transcriptional machinery. Other compounds in this class may extend the mRNA's stability, increasing its cellular lifespan, thereby boosting protein levels.
Beyond gene expression, AHI1 Activators also potentially impact the post-translational behavior of the AHI1 protein. By inhibiting protein degradation or enhancing protein functionality, these activators ensure greater abundance and activity of AHI1 in cells. The diversity among AHI1 Activators is notable, encompassing a spectrum from small organic molecules to larger, more complex biochemical entities. Variations in their delivery methods and cellular absorption rates add another layer of complexity, influencing their effectiveness across different cellular environments. A critical aspect of these activators is their specificity for the AHI1 protein, crucial for determining their efficacy and precision in modulating AHI1-associated cellular activities. Ongoing research delves into the intricate interactions between AHI1 Activators and the AHI1 protein or gene, aiming to elucidate the detailed mechanisms underlying these interactions. This understanding is vital for comprehending the molecular functioning of these activators and their role in influencing AHI1 activity within various cellular contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Could increase AHI1 expression by altering chromatin structure, making the gene more accessible for transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
As a glucocorticoid, it could influence AHI1 expression indirectly through stress response pathways, potentially leading to upregulation. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
Might upregulate AHI1 expression indirectly through interactions with serotonin pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Could enhance AHI1 expression, as it is involved in gene regulation and expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Might upregulate AHI1 indirectly by influencing cellular differentiation and development. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As an HDAC inhibitor, it may increase AHI1 expression by enhancing transcriptional accessibility of the gene. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Could influence AHI1 expression indirectly through modulation of mood and neurological function, potentially leading to an upregulation of AHI1. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Might potentially upregulate AHI1 as part of its broad effects on cellular metabolism and gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
May upregulate AHI1 by increasing chromatin accessibility and promoting transcription. | ||||||